Physician profile
Jane Park
NPI 1700939956
$6,292.96
in general payments reported to CMS, 2019-2025
18 companies · $51.34 in 2025
The $51.34 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,873 · 2020: $47.29 · 2021: $181 · 2022: $141 · 2025: $51.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,314.85 | 2019-2021 | |
| Davol INC. | $171.10 | 2019-2021 | |
| Convatec INC. | $152.50 | 2019-2022 | |
| Smith+Nephew, INC. | $146.23 | 2019 | |
| Allergan, INC. | $130.00 | 2019 | |
| Innovation Technologies INC | $107.01 | 2021 | |
| Conmed Corporation | $69.73 | 2019-2025 | Airseal |
| Boston Scientific Corporation | $37.17 | 2025 | Axonics |
| Covidien Lp | $21.75 | 2020 | |
| Integra Lifesciences Corporation | $20.60 | 2022 | |
| Organogenesis INC. | $19.99 | 2022 | |
| Next Science LLC | $19.90 | 2019 | |
| Meridian Bioscience INC. | $19.46 | 2019 | |
| Ethicon US, LLC | $15.81 | 2021 | |
| Genentech USA, INC. | $14.28 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $12.68 | 2019 | |
| Amgen INC. | $12.58 | 2020 | |
| Thd America, INC. | $7.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.